Rhome Research
B2CDoes not present first-party testing; uses publicly aggregated third-party benchmark signals (e.g., Finnrick-linked records) to surface transparency evidence.
Profile aggregated from Peptigrity — attributed.
Weighted blend of independent signals — Finnrick safety grade, VialAudit blind-buy audit, and Peptigrity HPLC purity. PeptideBenchmark and the Peptigrity trust score are excluded to avoid double-counting. Attributed to its sources — not our verdict.
Independent test grades (1)
Per Finnrick (independent testing). Attributed — Finnrick's grades, not ours.
| Peptide | Grade | Score |
|---|---|---|
| CJC-1295 | E | — |
Independent HPLC tests (11)
Real third-party HPLC results for this vendor, aggregated from Peptigrity and attributed to the lab that ran each test.
| Peptide | HPLC purity | Lab | Date |
|---|---|---|---|
| BPC-157 | 99.91% | freedomdiagnosticstesting.com | 2026-06-22 |
| Retatrutide | 99.60% | freedomdiagnosticstesting.com | 2026-06-20 |
| CJC-1295 | 99.60% | freedomdiagnosticstesting.com | 2026-06-17 |
| Ipamorelin | 99.90% | freedomdiagnosticstesting.com | 2026-06-17 |
| GHK-Cu | 99.31% | freedomdiagnosticstesting.com | 2026-05-27 |
| Thymosin alpha-1 | 99.44% | freedomdiagnosticstesting.com | 2026-05-20 |
| Glutathione |
Other independent ratings
Vendor-level scores from other independent aggregators, shown for cross-reference. Attributed — each source's score, not ours.